Chemicals · Founded 1929 · www.ivpindia.com · BSE 507580 · NSE IVP LIMITED · ISIN INE043C01018
No Notes Added Yet
Business
IVP Ltd. is an Indian company primarily engaged in the manufacturing and marketing of a diversified range of specialty chemicals. Its core business revolves around three main product categories: foundry chemicals, various types of resins, and speciality oils. The company serves a wide array of industrial clients across sectors such as automotive, infrastructure, construction, paints, printing inks, electrical insulation, and general manufacturing. IVP makes money by manufacturing these specialized chemical products and selling them to industrial customers, often requiring specific technical formulations and consistent quality.
Revenue Mix
IVP's business is generally segmented into the following major product lines:
Foundry Chemicals: Products used in metal casting processes, including binders, coatings, and fluxes.
Resins: A variety of synthetic resins used in industries like paints, coatings, adhesives, printing inks, and electrical insulation. This includes alkyd resins, phenolic resins, epoxy esters, and insulating varnishes.
Speciality Oils: Includes transformer oils (for electrical equipment), white oils (for cosmetics, pharmaceuticals), and other industrial oils.
Specific revenue contributions for each segment are not readily available in a general overview without access to the latest detailed annual reports.
Industry
IVP operates within the broader Indian Chemicals sector, specifically in the specialty chemicals segment. This industry is characterized by a mix of large integrated players and niche manufacturers. IVP holds a long-standing presence (established 1929) and is positioned as an experienced player, particularly in its niche areas like foundry chemicals and certain resin types. It competes with both domestic and international manufacturers of specialty chemicals, often focusing on customized solutions and technical expertise rather than sheer volume. Its products cater to specific industrial applications where performance and reliability are critical.
MOAT
Legacy and Experience: Being established in 1929, IVP possesses significant accumulated technical expertise, deep industry knowledge, and long-standing relationships with industrial clients.
Product Specialization: Focus on specialty chemicals often involves proprietary formulations and customization, leading to higher entry barriers for competitors and potentially higher switching costs for customers compared to commodity chemicals.
Customer Relationships: Decades of operation have likely resulted in strong, enduring relationships with key customers in various industrial sectors.
Godrej Group Backing: As part of the Godrej & Boyce Manufacturing Co. Ltd. group (via Godrej Industries Ltd.), IVP benefits from the brand reputation, financial strength, and corporate governance standards of a well-respected conglomerate.
Growth Drivers
Industrial Growth in India: Sustained growth in key end-user industries such as automotive, manufacturing, construction, and electricals will directly drive demand for IVP's products.
Infrastructure Development: Government focus and investments in infrastructure projects will boost demand for construction materials, paints, and related industrial chemicals.
New Product Development & Customization: Ability to innovate and develop specialized products meeting evolving industry standards and customer requirements (e.g., eco-friendly formulations) can unlock new growth avenues.
Capacity Utilization & Expansion: Optimizing existing capacity and strategic expansions in high-demand segments can lead to increased sales volume.
Increasing Sophistication of Indian Manufacturing: As Indian industries adopt more advanced manufacturing processes, demand for higher-quality, specialized chemicals like those produced by IVP will increase.
Risks
Raw Material Price Volatility: The company is susceptible to fluctuations in prices of crude oil derivatives and other key chemical raw materials, which can impact production costs and profitability.
Economic Downturns: As a supplier to cyclical industries (e.g., automotive, construction), IVP's demand and revenue are sensitive to broader economic slowdowns or industrial activity contractions.
Intense Competition: The specialty chemicals market in India is competitive, with domestic and international players, which can lead to pricing pressures and margin erosion.
Regulatory & Environmental Compliance: Operating in the chemical industry involves stringent environmental regulations, requiring continuous investment in compliance and potentially facing operational restrictions or penalties.
Technological Obsolescence: Rapid technological changes in end-user industries necessitate continuous R&D and adaptation of product formulations to remain relevant.
Management & Ownership
IVP Ltd. is part of the esteemed Godrej Group, with Godrej Industries Ltd. and its related entities holding a significant promoter stake. This association implies a strong corporate governance framework and access to professional management practices. The management team is expected to be aligned with the broader strategic vision and values of the Godrej conglomerate. The significant promoter holding provides stability and long-term strategic guidance.
Outlook
IVP Ltd. holds a robust position in its niche specialty chemical segments, backed by a long history, technical expertise, and the strong foundation of the Godrej Group. The company is well-placed to capitalize on India's projected industrial growth, increasing infrastructure spending, and the rising demand for specialized materials across various sectors. However, its performance is susceptible to volatility in raw material prices and cyclical shifts in its end-user industries. The ability to continually innovate, manage costs effectively, and maintain strong customer relationships will be crucial in navigating the competitive landscape and sustaining profitability.
| #(Fig in Cr.) | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 142 | 138 | 122 | 129 | 149 | 138 | 147 | 145 | 164 | 155 |
| Other Income | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Total Income | 143 | 139 | 123 | 130 | 150 | 139 | 148 | 146 | 166 | 156 |
| Total Expenditure | 133 | 131 | 116 | 124 | 142 | 134 | 139 | 136 | 151 | 134 |
| Operating Profit | 10 | 8 | 6 | 6 | 9 | 5 | 9 | 10 | 15 | 22 |
| Interest | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 1 | 2 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 |
| Profit Before Tax | 6 | 4 | 3 | 3 | 5 | 2 | 5 | 6 | 12 | 19 |
| Provision for Tax | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 3 | 5 |
| Profit After Tax | 5 | 3 | 2 | 2 | 4 | 1 | 4 | 5 | 9 | 14 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 5 | 3 | 2 | 2 | 4 | 1 | 4 | 5 | 9 | 14 |
| Adjusted Earnings Per Share | 4.6 | 3.3 | 2.1 | 1.8 | 3.7 | 1.2 | 3.9 | 4.5 | 8.6 | 13.6 |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 155 | 162 | 270 | 320 | 229 | 290 | 557 | 661 | 546 | 539 | 595 | 611 |
| Other Income | 5 | 1 | 1 | 2 | 2 | 4 | 4 | 3 | 4 | 4 | 4 | 4 |
| Total Income | 160 | 163 | 272 | 322 | 231 | 294 | 560 | 664 | 550 | 543 | 599 | 616 |
| Total Expenditure | 140 | 144 | 249 | 311 | 229 | 275 | 522 | 621 | 519 | 514 | 560 | 560 |
| Operating Profit | 20 | 19 | 22 | 12 | 2 | 19 | 38 | 42 | 31 | 29 | 39 | 56 |
| Interest | 0 | 0 | 3 | 8 | 10 | 7 | 10 | 12 | 9 | 8 | 7 | 6 |
| Depreciation | 1 | 1 | 3 | 3 | 5 | 5 | 5 | 5 | 6 | 6 | 6 | 7 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 13 | 0 | 0 | -0 | 0 |
| Profit Before Tax | 18 | 17 | 16 | 0 | -13 | 7 | 23 | 38 | 17 | 15 | 25 | 42 |
| Provision for Tax | 8 | 6 | 6 | -3 | -4 | 2 | 6 | 10 | 4 | 4 | 6 | 11 |
| Profit After Tax | 10 | 11 | 10 | 3 | -9 | 5 | 18 | 28 | 12 | 11 | 19 | 32 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 10 | 11 | 10 | 3 | -9 | 5 | 18 | 28 | 12 | 11 | 19 | 32 |
| Adjusted Earnings Per Share | 10.1 | 10.5 | 10.1 | 3.3 | -8.3 | 4.4 | 17.1 | 27.1 | 11.9 | 10.9 | 18.1 | 30.6 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 10% | -3% | 15% | 14% |
| Operating Profit CAGR | 34% | -2% | 15% | 7% |
| PAT CAGR | 73% | -12% | 31% | 7% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | 34% | 7% | 12% | 5% |
| ROE Average | 13% | 10% | 16% | 11% |
| ROCE Average | 14% | 12% | 14% | 14% |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 63 | 73 | 81 | 82 | 72 | 76 | 92 | 119 | 130 | 139 | 157 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 3 | 2 | 27 | 23 | 19 | 21 | 29 | 4 | 42 | 46 | 34 |
| Total Current Liabilities | 39 | 59 | 163 | 193 | 148 | 228 | 276 | 261 | 198 | 206 | 184 |
| Total Liabilities | 105 | 134 | 271 | 297 | 239 | 325 | 397 | 384 | 370 | 391 | 375 |
| Fixed Assets | 16 | 35 | 41 | 57 | 84 | 79 | 74 | 73 | 71 | 72 | 67 |
| Other Non-Current Assets | 2 | 5 | 50 | 57 | 27 | 28 | 31 | 4 | 43 | 46 | 37 |
| Total Current Assets | 87 | 94 | 180 | 184 | 127 | 217 | 291 | 306 | 255 | 273 | 271 |
| Total Assets | 105 | 134 | 271 | 297 | 239 | 325 | 397 | 384 | 370 | 391 | 375 |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 3 | 11 | 4 | 3 | 3 | 0 | 2 | 1 | 1 | 2 | 1 |
| Cash Flow from Operating Activities | 15 | 5 | -30 | -27 | 56 | -14 | -21 | 41 | 45 | -2 | 53 |
| Cash Flow from Investing Activities | 0 | -24 | -28 | -28 | -5 | -0 | -3 | 10 | -3 | -5 | -3 |
| Cash Flow from Financing Activities | -7 | 7 | 58 | 54 | -54 | 16 | 23 | -51 | -41 | 6 | -48 |
| Net Cash Inflow / Outflow | 8 | -11 | -0 | -0 | -3 | 1 | -1 | -0 | 1 | -1 | 2 |
| Closing Cash & Cash Equivalent | 11 | -0 | 3 | 3 | 0 | 2 | 1 | 1 | 2 | 1 | 3 |
| # | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 10.09 | 10.47 | 10.06 | 3.27 | -8.34 | 4.36 | 17.07 | 27.12 | 11.89 | 10.95 | 18.08 |
| CEPS(Rs) | 11.28 | 11.79 | 12.58 | 6.04 | -3.64 | 9.25 | 22.02 | 32.16 | 17.25 | 16.5 | 23.9 |
| DPS(Rs) | 2 | 2 | 2 | 1 | 0 | 1 | 1.5 | 1.5 | 1 | 1 | 1.5 |
| Book NAV/Share(Rs) | 59.64 | 70.87 | 78.49 | 78.97 | 69.47 | 73.28 | 88.78 | 114.89 | 125.48 | 134.88 | 152.07 |
| Core EBITDA Margin(%) | 8.47 | 9.67 | 7.56 | 2.93 | -0.03 | 4.96 | 6.27 | 5.98 | 5 | 4.59 | 5.81 |
| EBIT Margin(%) | 10.73 | 9.56 | 7.15 | 2.71 | -1.16 | 4.71 | 5.98 | 7.59 | 4.64 | 4.28 | 5.47 |
| Pre Tax Margin(%) | 10.46 | 9.43 | 5.96 | 0.09 | -5.61 | 2.31 | 4.2 | 5.74 | 3.05 | 2.83 | 4.23 |
| PAT Margin (%) | 6.04 | 5.99 | 3.77 | 1.06 | -3.77 | 1.55 | 3.17 | 4.24 | 2.25 | 2.1 | 3.14 |
| Cash Profit Margin (%) | 6.76 | 6.74 | 4.71 | 1.95 | -1.64 | 3.3 | 4.09 | 5.03 | 3.26 | 3.16 | 4.15 |
| ROA(%) | 10.53 | 9.05 | 5.13 | 1.19 | -3.21 | 1.6 | 4.89 | 7.18 | 3.26 | 2.97 | 4.88 |
| ROE(%) | 18.08 | 16.04 | 13.47 | 4.16 | -11.24 | 6.1 | 21.06 | 26.64 | 9.89 | 8.41 | 12.6 |
| ROCE(%) | 31.01 | 23.19 | 16.03 | 4.53 | -1.35 | 7.4 | 14.92 | 20.63 | 11.08 | 9.96 | 13.95 |
| Receivable days | 122.59 | 116.43 | 110.18 | 130.75 | 171.38 | 145.86 | 113.95 | 114.83 | 126.64 | 119.72 | 113.1 |
| Inventory Days | 31.26 | 45.39 | 57.17 | 62.13 | 63.49 | 64.85 | 49.59 | 47.04 | 55.93 | 53.95 | 48.29 |
| Payable days | 60.23 | 69.27 | 76.88 | 74.22 | 90 | 117.66 | 84.22 | 82.11 | 98.32 | 83.69 | 78.97 |
| PER(x) | 8.28 | 16.97 | 19.1 | 38.81 | 0 | 22.34 | 8.68 | 4.44 | 12.82 | 13.19 | 6.15 |
| Price/Book(x) | 1.4 | 2.51 | 2.45 | 1.61 | 0.46 | 1.33 | 1.67 | 1.05 | 1.21 | 1.07 | 0.73 |
| Dividend Yield(%) | 2.4 | 1.13 | 1.04 | 0.79 | 0 | 1.03 | 1.01 | 1.25 | 0.66 | 0.69 | 1.35 |
| EV/Net Sales(x) | 0.49 | 1.2 | 1.01 | 0.85 | 0.58 | 0.76 | 0.55 | 0.37 | 0.45 | 0.47 | 0.3 |
| EV/Core EBITDA(x) | 3.81 | 10.41 | 12.22 | 23.46 | 60.13 | 11.81 | 8.04 | 5.72 | 7.92 | 8.77 | 4.54 |
| Net Sales Growth(%) | -5.35 | 4.41 | 67.23 | 18.44 | -28.49 | 26.63 | 92.14 | 18.75 | -17.38 | -1.33 | 10.34 |
| EBIT Growth(%) | 68.27 | -6.71 | 14.23 | -55.94 | -130.65 | 613.16 | 143.88 | 50.77 | -49.53 | -9 | 41.04 |
| PAT Growth(%) | 50.34 | 3.77 | -3.86 | -67.47 | -355.03 | 152.2 | 291.78 | 58.93 | -56.17 | -7.9 | 65.16 |
| EPS Growth(%) | 50.35 | 3.77 | -3.9 | -67.47 | -355.03 | 152.2 | 291.78 | 58.93 | -56.17 | -7.9 | 65.16 |
| Debt/Equity(x) | 0 | 0.19 | 0.96 | 1.75 | 1.38 | 1.62 | 1.71 | 1.01 | 0.69 | 0.75 | 0.42 |
| Current Ratio(x) | 2.22 | 1.61 | 1.1 | 0.95 | 0.86 | 0.95 | 1.05 | 1.18 | 1.29 | 1.32 | 1.47 |
| Quick Ratio(x) | 1.75 | 1.15 | 0.73 | 0.7 | 0.65 | 0.64 | 0.77 | 0.82 | 0.91 | 0.92 | 1.07 |
| Interest Cover(x) | 40.06 | 76.58 | 5.99 | 1.03 | -0.26 | 1.96 | 3.35 | 4.1 | 2.91 | 2.96 | 4.41 |
| Total Debt/Mcap(x) | 0 | 0.08 | 0.39 | 1.09 | 2.98 | 1.22 | 1.02 | 0.96 | 0.57 | 0.7 | 0.57 |
| # | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 71.32 | 71.32 | 71.32 | 71.32 | 71.32 | 71.32 | 71.32 | 71.32 | 71.32 | 71.32 |
| FII | 0.01 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.04 |
| DII | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |
| Public | 28.66 | 28.66 | 28.66 | 28.66 | 28.66 | 28.66 | 28.66 | 28.66 | 28.66 | 28.62 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 0.74 | 0.74 | 0.74 | 0.74 | 0.74 | 0.74 | 0.74 | 0.74 | 0.74 | 0.74 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1.03 | 1.03 | 1.03 | 1.03 | 1.03 | 1.03 | 1.03 | 1.03 | 1.03 | 1.03 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | +10% | -3% | +15% | +14% |
| Operating Profit CAGR | +34% | -2% | +15% | +7% |
| PAT CAGR | +73% | -12% | +31% | +7% |
| Share Price CAGR | +34% | +7% | +12% | +5% |
| ROE Average | +13% | +10% | +16% | +11% |
| ROCE Average | +14% | +12% | +14% | +14% |
| # | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 71.32 | 71.32 | 71.32 | 71.32 | 71.32 | 71.32 | 71.32 | 71.32 | 71.32 | 71.32 |
| FII | 0.01 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.04 |
| DII | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |
| Public | 28.66 | 28.66 | 28.66 | 28.66 | 28.66 | 28.66 | 28.66 | 28.66 | 28.66 | 28.62 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 0.74 | 0.74 | 0.74 | 0.74 | 0.74 | 0.74 | 0.74 | 0.74 | 0.74 | 0.74 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1.03 | 1.03 | 1.03 | 1.03 | 1.03 | 1.03 | 1.03 | 1.03 | 1.03 | 1.03 |
* The pros and cons are machine generated.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.
Your relationship manager will connect with you shortly.